Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomized controlled trials and cohort studies.

Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies – BMJ Medicine

Related:

PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations – The BMJ

PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis – The BMJ

Commentary on Twitter

Read a new #systematicreview and meta-analysis of RCTs and cohort studies on the safety of #Ezetimibe in lipid-lowering treatment. ▶️ https://t.co/mr4H5MfVdP#VisualAbstract #RapidRecommendations@bmj_latest @theMAGICapp pic.twitter.com/OLg0HZr8D3

— BMJMedicine (@BMJMedicine) May 5, 2022